UniSa - IRIS Institutional Research Information System

TERRACCIANO, Stefania
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 7.661
NA - Nord America 3.963
EU - Europa 1.643
SA - Sud America 329
Continente sconosciuto - Info sul continente non disponibili 156
AF - Africa 36
OC - Oceania 3
Totale 13.791
Salva come PNG Salva come JPEG
Nazione #
HK - Hong Kong 6.056
US - Stati Uniti d'America 3.847
IT - Italia 718
SG - Singapore 696
CN - Cina 387
BR - Brasile 243
VN - Vietnam 191
RU - Federazione Russa 189
DE - Germania 185
UA - Ucraina 145
TR - Turchia 68
FR - Francia 64
IE - Irlanda 64
CA - Canada 62
SE - Svezia 61
GB - Regno Unito 57
IN - India 56
FI - Finlandia 52
KR - Corea 40
BD - Bangladesh 30
MX - Messico 30
AR - Argentina 29
JP - Giappone 29
NL - Olanda 21
PL - Polonia 19
ID - Indonesia 14
AT - Austria 13
CO - Colombia 13
CZ - Repubblica Ceca 13
ES - Italia 13
EC - Ecuador 12
IQ - Iraq 12
PH - Filippine 12
ZA - Sudafrica 12
PK - Pakistan 10
CL - Cile 9
UZ - Uzbekistan 9
VE - Venezuela 9
AZ - Azerbaigian 8
HU - Ungheria 6
MA - Marocco 6
SA - Arabia Saudita 6
DO - Repubblica Dominicana 5
MY - Malesia 5
OM - Oman 5
AE - Emirati Arabi Uniti 4
CR - Costa Rica 4
EG - Egitto 4
PE - Perù 4
RO - Romania 4
CH - Svizzera 3
GT - Guatemala 3
JM - Giamaica 3
JO - Giordania 3
KE - Kenya 3
KZ - Kazakistan 3
LT - Lituania 3
NP - Nepal 3
PR - Porto Rico 3
PY - Paraguay 3
RS - Serbia 3
UY - Uruguay 3
AU - Australia 2
BG - Bulgaria 2
BO - Bolivia 2
DK - Danimarca 2
EU - Europa 2
HN - Honduras 2
IL - Israele 2
IR - Iran 2
PA - Panama 2
PS - Palestinian Territory 2
TJ - Tagikistan 2
TN - Tunisia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AO - Angola 1
BE - Belgio 1
BH - Bahrain 1
BY - Bielorussia 1
ET - Etiopia 1
GA - Gabon 1
GF - Guiana Francese 1
GY - Guiana 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LC - Santa Lucia 1
ML - Mali 1
MN - Mongolia 1
MU - Mauritius 1
NG - Nigeria 1
NO - Norvegia 1
PT - Portogallo 1
PW - Palau 1
QA - Qatar 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TT - Trinidad e Tobago 1
Totale 13.637
Salva come PNG Salva come JPEG
Città #
Hong Kong 6.039
Ann Arbor 579
Singapore 409
Dallas 329
San Jose 316
Chandler 306
Woodbridge 236
Ashburn 218
Milan 212
Jacksonville 174
Wilmington 170
Princeton 166
Houston 158
Salerno 103
Beijing 91
The Dalles 79
Council Bluffs 67
Dublin 62
Munich 59
Lauterbourg 55
Izmir 53
Ho Chi Minh City 52
Los Angeles 50
Naples 50
Rome 49
New York 47
Nanjing 46
Hanoi 44
Andover 35
Montreal 35
Orem 31
Santa Clara 31
Boardman 30
Dearborn 29
Tokyo 29
Pellezzano 28
Memphis 24
Moscow 24
Turku 24
Fisciano 23
São Paulo 22
Frankfurt am Main 20
Stockholm 19
Brooklyn 17
Chengdu 17
Redwood City 17
Warsaw 17
Guangzhou 16
Boston 15
Chennai 15
Columbus 15
Denver 15
Fairfield 15
Figino 15
Nuremberg 15
Mexico City 13
Phoenix 13
Turin 13
Da Nang 12
Dong Ket 12
Jiaxing 12
London 12
Changsha 11
Hebei 11
Atlanta 10
Brno 10
Chicago 10
Johannesburg 10
Amsterdam 9
Belo Horizonte 9
Nanchang 9
Seattle 9
Shenyang 9
Washington 9
Charlotte 8
Düsseldorf 8
Hải Dương 8
Manchester 8
Mestre 8
New Delhi 8
San Francisco 8
Baku 7
Norwalk 7
Pune 7
Ankara 6
Curitiba 6
Dhaka 6
Ottawa 6
Tashkent 6
Baghdad 5
Biên Hòa 5
Caianello 5
Campinas 5
Chandigarh 5
Falls Church 5
Haiphong 5
Jakarta 5
Jinan 5
Medellín 5
Montoro 5
Totale 11.177
Salva come PNG Salva come JPEG
Nome #
A Combinatorial Virtual Screening Approach Driving the Synthesis of 2,4-Thiazolidinedione-Based Molecules as New Dual mPGES-1/5-LO Inhibitors 1.132
Inhibition of Microsomal Prostaglandin E2 Synthase 1: focused design of new anti-inflammatory and anti-cancer drugs 946
Identification of 2-(thiophen-2-yl)acetic Acid-Based Lead Compound for mPGES-1 Inhibition 645
Protein Preparation Automatic Protocol for High-Throughput Inverse Virtual Screening: Accelerating the Target Identification by Computational Methods 624
40 th "A. Corbella" International Summer School on Organic Synthesis - ISOS 2015 609
Chemistry and biology of anti-inflammatory marine natural products: molecules interfering with cyclooxygenase, NF-κB and other unidentified targets 551
Design, Synthesis, and Biological Activity of Hydroxamic Tertiary Amines as Histone Deacetylase Inhibitors 542
In Silico Design, Chemical Synthesis, Biophysical and in Vitro Evaluation for the Identification of 1-Ethyl-1H-Pyrazolo[3,4-b]Pyridine-Based BRD9 Binders 523
Identification of Novel Bromodomain-Containing Protein 4 (BRD4) Binders through 3D Pharmacophore-Based Repositioning Screening Campaign 404
Identification of the 2-Benzoxazol-2-yl-phenol Scaffold as New Hit for JMJD3 Inhibition 372
9H-purine scaffold reveals induced-fit pocket plasticity of the BRD9 bromodomain 262
Cyclic Peptoids as Mycotoxin Mimics: An Exploration of Their Structural and Biological Properties 214
From Natural Compounds to Bioactive Molecules through NMR and In Silico Methodologies 210
Can Small Chemical Modifications of Natural Pan-inhibitors Modulate the Biological Selectivity? the Case of Curcumin Prenylated Derivatives Acting as HDAC or mPGES-1 Inhibitors 209
Exploration of the dihydropyrimidine scaffold for the development of new potential anti-inflammatory agents blocking prostaglandin E2 synthase-1 enzyme (mPGES-1) 196
Structural basis for the design and synthesis of selective HDAC inhibitors 195
Targeting the Hsp90 C-terminal domain by the chemically accessible dihydropyrimidinone scaffold 193
Structural Insights for the Optimization of Dihydropyrimidin-2(1H)-one Based mPGES-1 Inhibitors 190
Synthesis, Conformational Analysis, and Cytotoxicity of New Analogues of the Natural Cyclodepsipeptide Jaspamide 181
Identification of the key structural elements of a dihydropyrimidinone core driving toward more potent Hsp90 C-terminal inhibitors 177
Dimeric and trimeric triazole based molecules as a new class of Hsp90 molecular chaperone inhibitors 174
Design and Synthesis of cyclopeptide analogues of the potent Histone deacetylase inhibitor FR235222 171
Identification of Lead Compounds as Inhibitors of STAT3: Design, Synthesis and Bioactivity 168
Correction: Identification of the key structural elements of a dihydropyrimidinone core driving toward more potent Hsp90 C-terminal inhibitors 168
Design,virtual Screening and Synthesis of Potential Microsomal Prostaglandine E2 Synthase-1 (mPGES-1)Inhibitors 167
Identification of novel microsomal prostaglandin E2 synthase-1 (mPGES-1) lead inhibitors from Fragment Virtual Screening 167
New dihydropyrimidin-2(1H)-one based Hsp90 C-terminal inhibitors 165
Identification of 2,4,5-trisubstituted-2,4-dihydro-3H-1,2,4-triazol-3-one-based small molecules as selective BRD9 binders 164
Effects of FR235222, a novel HDAC inhibitor, in proliferation and apoptosis of human leukaemia cell lines: role of annexin A1 152
Identification of Honokiol-Based Scaffold to Design Tankyrase 1/2 Inhibitors by In Silico and In Vitro Studies 150
Virtual screening of 3-(1H-1,2,3-triazol-1-yl)piperidine-2,6-dione-based compounds as new potential Cereblon modulators amenable for targeted protein degradation 148
Targeting Microsomal Prostaglanding E2 Synthase 1 for the Development of new potential Anti-Inflammatory Drugs 145
Discovery of new potent molecular entities able to inhibit mPGES-1 145
Chemistry and Biology of Anti-Inflammatory Marine Natural Products.Phospholipase A2 Inhibitors 137
Discovery and synthesis of the first selective BAG domain modulator of BAG3 as an attractive candidate for the development of a new class of chemotherapeutics 137
Conformationally locked calixarene-based histone deacetylase inhibitors 136
2-Substituted 1,5-benzothiazepine-based HDAC inhibitors exert anticancer activities on human solid and acute myeloid leukemia cell lines 135
Total Synthesis, NMR Solution Structure, and Binding Model of the Potent Histone Deacetylase Inhibitor FR235222 134
Hsp90 Activity Modulation by Plant Secondary Metabolites 134
Structure-Based Design of Microsomal Prostaglandin E2 Synthase-1 (mPGES-1) Inhibitors using a Virtual Fragment Growing Optimization Scheme 134
Chemoproteomics Reveals USP5 (Ubiquitin Carboxyl-Terminal Hydrolase 5) as Promising Target of the Marine Polyketide Gracilioether A 133
Discovery of new molecular entities able to strongly interfere with Hsp90 C-terminal domain 130
Critical Surveys Covering the Year 2004:Total Synthesis of Natural Products 129
Synthesis of new mono and bis amides projected as potential histone deacetylase (HDAC) inhibitors 129
Molecular modeling studies toward the structural optimization of new cyclopeptide-based HDAC inhibitors modeled on the natural product FR235222 128
A multidisciplinary functional proteomics-aided strategy as a tool for the profiling of a novel cytotoxic thiadiazolopyrimidone 121
Identification by Inverse Virtual Screening of magnolol-based scaffold as new tankyrase-2 inhibitors 120
Identification of the first-in-class dual inhibitor targeting BAG3 and HSP70 proteins to disrupt multiple chaperone pathways 119
Synthetic and pharmacological studies on new simplified analogues of the potent actin-targeting Jaspamide 119
Glucopyranosylbianthrones from the Algerian Asphodelus tenuifolius: Structural Insights and Biological Evaluation on Melanoma Cancer Cells 118
Structural Refinement of 2,4-Thiazolidinedione Derivatives as New Anticancer Agents Able to Modulate the BAG3 Protein 108
Discovery of noscapine derivatives as potential β-tubulin inhibitors 107
Synthesis and biological activity of cyclotetrapeptide analogues of the natural HDAC inhibitor FR235222 106
Exploring the chemical space of functionalized [1,2,4]triazolo[4,3-a]quinoxaline-based compounds targeting the bromodomain of BRD9 99
Repositioning of Quinazolinedione-Based Compounds on Soluble Epoxide Hydrolase (sEH) through 3D Structure-Based Pharmacophore Model-Driven Investigation 97
Introducing structure-based three-dimensional pharmacophore models for accelerating the discovery of selective BRD9 binders 93
Synthesis, solution structure, and bioactivity of six new simplified analogues of the natural cyclodepsipeptide jaspamide 86
Targeting mPGES-1 by a Combinatorial Approach: Identification of the Aminobenzothiazole Scaffold to Suppress PGE2Levels 83
Identification of 2,4-Dinitro-Biphenyl-Based Compounds as MAPEG Inhibitors 74
Identification of a New Promising BAG3 Modulator Featuring the Imidazopyridine Scaffold 72
Identification of 2-Aminoacyl-1,3,4-thiadiazoles as Prostaglandin E2 and Leukotriene Biosynthesis Inhibitors 54
A Thiadiazolopyrimidinone-Based Molecule Targeting Annexin A6 Impairs Cell Motility and Epithelial-to-Mesenchymal Transition in Pancreatic Cancer Cells Lacking Annexin A1 28
Identification of a New Interesting BAG3 Modulator Able to Disrupt Cancer-Related Pathways 25
Unveiling New Triazoloquinoxaline‐Based PROTACs Designed for the Selective Degradation of the ncBAF Chromatin Remodeling Subunit BRD9 24
Disruption of c-Myc/Max heterodimerization induced by a novel anticancer agent endowed with 1,3-diphenylurea moiety: an in silico, chemoproteomics-based, and in vitro combined approach 20
The future of BRD9 inhibitors: a patent perspective (2019-present) 19
Carnosol modulates mPGES-1/PPAR-γ biological axis: from in silico to in vivo clinical imaging and investigations 17
From Bench to Bedside: Translational Approaches to Cardiotoxicity in Breast Cancer, Lung Cancer, and Lymphoma Therapies 15
Advancing Non-Small-Cell Lung Cancer Management Through Multi-Omics Integration: Insights from Genomics, Metabolomics, and Radiomics 9
Discovery of New Antioxidant Molecules Enhancing the Nrf2-Mediated Pathway: Docking Studies and Biological Evaluation 3
Totale 13.791
Salva come PNG Salva come JPEG
Categoria #
all - tutte 34.599
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.599
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022311 0 0 0 5 9 8 10 11 49 38 45 136
2022/2023641 52 73 18 106 65 121 5 67 81 0 35 18
2023/2024288 20 42 20 12 38 54 13 22 6 8 10 43
2024/2025951 30 7 6 43 28 80 230 65 129 47 123 163
2025/20269.297 1.665 2.574 2.414 314 422 200 446 108 242 417 123 372
2026/2027146 111 35 0 0 0 0 0 0 0 0 0 0
Totale 13.791